文献速递眼底病与葡萄膜炎

遗传风险评分分析支持年龄相关性黄斑变性两种分类系统的联合观点

Genetic Risk Score Analysis Supports a Joint View of Two Classification Systems for Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

在基于人群的AugUR研究两个独立横断面数据集中,对2188名70至95岁者用彩色眼底图像按CC和3CACSS两种系统分级AMD,计算50个晚期AMD变异位点的遗传风险评分(GRS)。两系统对应关系支持一个7步联合量表,随AMD严重度增加GRS关联和诊断准确度逐步升高,限制对照后AUC亦升高。

要点

  • CC「年龄相关改变」和「早期AMD」可区分3CACSS「无AMD」者,3CACSS轻/中/重度早期AMD可区分CC「中期AMD」。
  • 据此提出7步量表:无AMD、年龄相关改变、极早期AMD、轻度早期AMD、中度早期AMD、重度早期AMD、晚期AMD。
  • 7步量表严重度增加及对照限制增加时,GRS关联与诊断准确度逐步升高。

核心结论

  • 临床和GRS数据支持使用7步联合量表,该整合简化了单独使用CC或3CACSS,并有助于锐化对照组。

研究设计与样本

  • 基于人群的AugUR研究两个独立横断面数据集,对2188名70至95岁者用彩色眼底图像按CC和3CACSS两种系统分级AMD。
  • 计算50个既往鉴定的晚期AMD变异位点的遗传风险评分,用逻辑回归评估关联并计算各AMD分期的曲线下面积(AUC)。

主要发现

  • CC「年龄相关改变」和CC「早期AMD」可区分3CACSS「无AMD」者,3CACSS「轻度/中度/重度早期AMD」分期可区分CC「中期AMD」。
  • 在7步量表中随AMD严重度增加,GRS关联和诊断准确度逐步升高。
  • 随对照限制增加诊断准确度升高,例如CC「无年龄相关改变的无AMD」:AUC=55.1%,95%CI=51.6,58.6;AUC=62.3%,95%CI=59.1,65.6;AUC=63.8%,95%CI=59.3,68.3;AUC=78.1%,95%CI=73.6,82.5;AUC=82.2%,95%CI=78.4,86.0;AUC=79.2%,95%CI=75.4,83.0。
  • 随玻璃膜疣大小和面积增加也观察到逐步升高。

关键数值与推荐

  • 7步量表为:(i)无AMD,(ii)年龄相关改变,(iii)极早期AMD(即CC早期),(iv)轻度早期AMD,(v)中度早期AMD,(vi)重度早期AMD,(vii)晚期AMD。
  • CC「无年龄相关改变的无AMD」条件下AUC依次为55.1%(95%CI=51.6,58.6)、62.3%(95%CI=59.1,65.6)、63.8%(95%CI=59.3,68.3)、78.1%(95%CI=73.6,82.5)、82.2%(95%CI=78.4,86.0)、79.2%(95%CI=75.4,83.0)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the utility of combining the Clinical Classification (CC) and the Three Continent age-related macular degeneration (AMD) Consortium Severity Scale (3CACSS) for classification of AMD. METHODS: In two independent cross-sectional datasets of our population-based AugUR study (Altersbezogene Untersuchungen zur Gesundheit der Universität Regensburg), we graded AMD via color fundus images applying two established classification systems (CC and 3CACSS). We calculated the genetic risk score (GRS) across 50 previously identified variants for late AMD, its association via logistic regression, and area under the curve (AUC) for each AMD stage. RESULTS: We analyzed 2188 persons aged 70 to 95 years. When comparing the two classification systems, we found a distinct pattern: CC "age-related changes" and CC "early AMD" distinguished individuals with 3CACSS "no AMD"; 3CACSS "mild/moderate/severe early AMD" stages, and distinguished CC "intermediate AMD". This suggested a 7-step scale combining the 2 systems: (i) "no AMD", (ii) "age-related changes", (iii) "very early AMD", (i.e. CC "early"), (iv) "mild early AMD", (v) "moderate early AMD", (vi) "severe early AMD", and (vii) "late AMD". GRS association and diagnostic accuracy increased stepwise by increased AMD severity in the 7-step scale and by increased restriction of controls (e.g. for CC "no AMD without age-related changes": AUC = 55.1%, 95% confidence interval [CI] = 51.6, 58.6, AUC = 62.3%, 95% CI = 59.1, 65.6, AUC = 63.8%, 95% CI = 59.3, 68.3, AUC = 78.1%, 95% CI = 73.6, 82.5, AUC = 82.2%, 95% CI = 78.4, 86.0, and AUC = 79.2%, 95% CI = 75.4, 83.0). A stepwise increase was also observed by increased drusen size and area. CONCLUSIONS: The utility of a 7-step scale is supported by our clinical and GRS data. This harmonization and full data integration provides an immediate simplification over using either CC or 3CACSS and helps to sharpen the control group.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Herold JM, Zimmermann ME, Gorski M, et al. Genetic Risk Score Analysis Supports a Joint View of Two Classification Systems for Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2023. PMID: 37721739. doi:10.1167/iovs.64.12.31

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。